Balance Sheet Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 20/09/2024 BST			5-day change	1st Jan Change
900.20 ^DKK	-0.71%		-2.45%	+16.61%

09-17	Inger Rydin Announces Executive Changes	CI
08-26	COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain

e1bf8b.hdn42HrIelmyc7c5k6od79w-_kX9Q7rOLUTo5WWalVc.8ZrAn0i7E27gJ-9p1N5qvaUNzw-nMun7eQengAaipwfGupSdMqYWHf8a-g

Published financial data: COLOPLAST A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2019	2020	2021	2022	2023
Revenues	17.94B	18.54B	19.43B	22.58B	24.5B
Total Revenues	17.94B	18.54B	19.43B	22.58B	24.5B
Cost of Goods Sold, Total	5.74B	5.93B	6.11B	7.05B	8.17B
Gross Profit	12.2B	12.61B	13.31B	15.53B	16.33B
Selling General & Admin Expenses, Total	5.96B	6.08B	6.25B	7.8B	8.63B
Stock-Based Compensation (IS)	7M	7M	2M	-2M	-1M
R&D Expenses	692M	708M	755M	866M	872M
Other Operating Expenses	-42M	-29M	-28M	-56M	-25M
Other Operating Expenses, Total	6.62B	6.76B	6.98B	8.61B	9.48B
Operating Income	5.58B	5.85B	6.34B	6.92B	6.85B
Interest Expense, Total	-6M	-30M	-25M	-172M	-638M
Interest And Investment Income	19M	8M	11M	12M	111M
Net Interest Expenses	13M	-22M	-14M	-160M	-527M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	2M	-248M	114M	-134M	-178M
Other Non Operating Income (Expenses)	-168M	-122M	-31M	-39M	-78M
EBT, Excl. Unusual Items	5.42B	5.46B	6.41B	6.59B	6.07B
Restructuring Charges	-43M	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-171M	-118M
Gain (Loss) On Sale Of Assets	16M	-	16M	-7M	-3M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-400M	-	-200M	-300M	-200M
Other Unusual Items	32M	11M	11M	19M	280M
EBT, Incl. Unusual Items	5.03B	5.47B	6.23B	6.13B	6.02B
Income Tax Expense	1.16B	1.27B	1.41B	1.42B	1.24B
Earnings From Continuing Operations	3.87B	4.2B	4.82B	4.71B	4.78B
Net Income to Company	3.87B	4.2B	4.82B	4.71B	4.78B
Net Income - (IS)	3.87B	4.2B	4.82B	4.71B	4.78B
Net Income to Common Incl Extra Items	3.87B	4.2B	4.82B	4.71B	4.78B
Net Income to Common Excl. Extra Items	3.87B	4.2B	4.82B	4.71B	4.78B
Per Share Items
Net EPS - Basic	18.24	19.74	22.67	22.15	22.21
Basic EPS - Continuing Operations	18.24	19.74	22.67	22.15	22.21
Basic Weighted Average Shares Outstanding	212M	213M	213M	212M	215M
Net EPS - Diluted	18.18	19.67	22.63	22.11	22.2
Diluted EPS - Continuing Operations	18.18	19.67	22.63	22.11	22.2
Diluted Weighted Average Shares Outstanding	213M	213M	213M	213M	216M
Normalized Basic EPS	15.97	16.04	18.81	19.37	17.6
Normalized Diluted EPS	15.91	15.98	18.78	19.34	17.59
Dividend Per Share	12	18	19	20	21
Payout Ratio	60.32	86.06	79.38	85.87	88.79
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	6.19B	6.45B	6.88B	7.54B	7.57B
EBITA	5.69B	5.96B	6.42B	7.11B	7.09B
EBIT	5.58B	5.85B	6.34B	6.92B	6.85B
EBITDAR	6.42B	6.48B	6.92B	7.6B	7.64B
Effective Tax Rate - (Ratio)	22.97	23.22	22.59	23.19	20.61
Total Current Taxes	1.27B	1.29B	1.2B	1.53B	4.61B
Total Deferred Taxes	-110M	-19M	216M	-98M	-3.34B
Normalized Net Income	3.39B	3.41B	4B	4.12B	3.79B
Interest on Long-Term Debt	-	14M	12M	132M	469M
Non-Cash Pension Expense	7M	2M	3M	2M	4M
Supplemental Operating Expense Items
Selling and Marketing Expenses	5.21B	5.32B	5.48B	6.8B	7.52B
General and Administrative Expenses	757M	762M	762M	1B	1.12B
Research And Development Expense From Footnotes	692M	708M	755M	866M	872M
Net Rental Expense, Total	229M	34M	41M	55M	67M
Imputed Operating Lease Interest Expense	8.56M	5.52M	3.62M	7.04M	17.87M
Imputed Operating Lease Depreciation	220M	28.48M	37.38M	47.96M	49.13M
Stock-Based Comp., Other (Total)	47M	47M	53M	49M	57M
Total Stock-Based Compensation	47M	47M	53M	49M	57M

Fiscal Period: September	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	356M	323M	448M	414M	911M
Short Term Investments	313M	262M	226M	219M	-
Total Cash And Short Term Investments	669M	585M	674M	633M	911M
Accounts Receivable, Total	3.15B	2.93B	3.21B	3.94B	4.32B
Other Receivables	428M	580M	508M	719M	805M
Total Receivables	3.58B	3.51B	3.72B	4.66B	5.12B
Inventory	1.93B	2.23B	2.43B	3.19B	3.52B
Prepaid Expenses	163M	163M	172M	293M	384M
Restricted Cash	13M	-	-	-	-
Total Current Assets	6.36B	6.49B	6.99B	8.77B	9.94B
Gross Property Plant And Equipment	8.3B	8.92B	9.48B	10.29B	11.1B
Accumulated Depreciation	-5.46B	-5.75B	-5.89B	-6.15B	-6.36B
Net Property Plant And Equipment	2.84B	3.16B	3.58B	4.13B	4.74B
Long-term Investments	5M	27M	41M	51M	65M
Goodwill	2.03B	1.98B	2.03B	11.81B	19.97B
Other Intangibles, Total	422M	312M	1.54B	8.3B	11.06B
Deferred Tax Assets Long-Term	590M	669M	743M	674M	884M
Other Long-Term Assets, Total	488M	864M	912M	1.22B	1.5B
Total Assets	12.73B	13.5B	15.84B	34.96B	48.16B
Liabilities
Accounts Payable, Total	859M	814M	1.04B	1.24B	1.29B
Accrued Expenses, Total	9M	13M	15M	6M	7M
Current Portion of Long-Term Debt	1.07B	1.11B	2.16B	1.64B	7.12B
Current Portion of Leases	8M	206M	177M	209M	230M
Current Income Taxes Payable	1.07B	1B	928M	1.34B	4.23B
Unearned Revenue Current, Total	11M	9M	8M	2M	1M
Other Current Liabilities	1.92B	1.82B	1.99B	2.89B	3.44B
Total Current Liabilities	4.94B	4.98B	6.31B	7.34B	16.31B
Long-Term Debt	-	-	-	16.36B	11.56B
Long-Term Leases	134M	430M	449M	496M	664M
Unearned Revenue Non Current	22M	11M	2M	7M	6M
Pension & Other Post Retirement Benefits	200M	176M	181M	115M	124M
Deferred Tax Liability Non Current	264M	369M	671M	2.08B	2.12B
Other Non Current Liabilities	257M	128M	56M	274M	75M
Total Liabilities	5.82B	6.09B	7.67B	26.66B	30.86B
Common Stock, Total	216M	216M	216M	216M	228M
Retained Earnings	6.92B	7.5B	8.38B	8.57B	18.23B
Comprehensive Income and Other	-228M	-315M	-433M	-495M	-1.16B
Total Common Equity	6.91B	7.41B	8.17B	8.29B	17.3B
Total Equity	6.91B	7.41B	8.17B	8.29B	17.3B
Total Liabilities And Equity	12.73B	13.5B	15.84B	34.96B	48.16B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	212M	213M	213M	212M	225M
ECS Total Common Shares Outstanding	212M	213M	213M	212M	225M
Book Value / Share	32.54	34.82	38.38	39.06	77
Tangible Book Value	4.46B	5.12B	4.6B	-11.82B	-13.73B
Tangible Book Value Per Share	21	24.06	21.62	-55.66	-61.12
Total Debt	1.21B	1.75B	2.79B	18.71B	19.57B
Net Debt	539M	1.16B	2.11B	18.08B	18.66B
Debt Equivalent of Unfunded Proj. Benefit Obligation	209M	189M	196M	121M	131M
Debt Equivalent Oper. Leases	1.83B	272M	328M	440M	536M
Equity Method Investments, Total	5M	27M	41M	51M	65M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	308M	420M	453M	621M	796M
Inventories - Work In Process, Total	441M	464M	580M	722M	755M
Inventories - Finished Goods, Total	1.18B	1.34B	1.4B	1.84B	1.97B
Land - (BS)	2.66B	2.47B	2.75B	3.17B	3.48B
Machinery, Total	5.64B	5.63B	6.13B	6.44B	6.78B
Full Time Employees	12.07K	12.43K	12.73K	14.57K	15.69K
Accumulated Allowance for Doubtful Accounts (Supple)	93M	122M	139M	108M	110M

Fiscal Period: September	2019	2020	2021	2022	2023
Net Income	3.87B	4.2B	4.82B	4.71B	4.78B
Depreciation & Amortization - CF	500M	692M	663M	670M	735M
Amortization of Goodwill and Intangible Assets - (CF)	118M	118M	82M	190M	245M
Depreciation & Amortization, Total	618M	810M	745M	860M	980M
Amortization of Deferred Charges, Total - (CF)	33M	41M	47M	70M	89M
(Gain) Loss From Sale Of Asset	-24M	2M	4M	7M	3M
Other Operating Activities, Total	148M	61M	-256M	305M	-736M
Change In Accounts Receivable	-222M	81M	-235M	-351M	-392M
Change In Inventories	-197M	-403M	-161M	-540M	-474M
Change In Accounts Payable	145M	120M	224M	337M	-38M
Change in Other Net Operating Assets	-17M	-150M	97M	-295M	11M
Cash from Operations	4.36B	4.76B	5.29B	5.1B	4.23B
Capital Expenditure	-617M	-846M	-919M	-927M	-1.02B
Sale of Property, Plant, and Equipment	47M	5M	36M	11M	8M
Cash Acquisitions	-	-	-97M	-10.63B	-7.92B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-73M	-85M	-1.05B	-208M	-221M
Investment in Marketable and Equity Securities, Total	-2M	25M	16M	-2M	199M
Other Investing Activities, Total	54M	-	-	-	-
Cash from Investing	-591M	-901M	-2.01B	-11.76B	-8.96B
Short Term Debt Issued, Total	-	45M	1.05B	-	622M
Long-Term Debt Issued, Total	-	-	-	16.37B	-
Total Debt Issued	-	45M	1.05B	16.37B	622M
Short Term Debt Repaid, Total	-196M	-	-	-5.4B	-
Long-Term Debt Repaid, Total	-	-197M	-202M	-239M	-244M
Total Debt Repaid	-196M	-197M	-202M	-5.64B	-244M
Issuance of Common Stock	380M	407M	306M	-	9.13B
Repurchase of Common Stock	-500M	-500M	-500M	-500M	-
Common Dividends Paid	-2.34B	-3.61B	-3.83B	-4.04B	-4.25B
Common & Preferred Stock Dividends Paid	-2.34B	-3.61B	-3.83B	-4.04B	-4.25B
Special Dividend Paid	-1.06B	-	-	-	-
Other Financing Activities, Total	-	-	-	402M	-
Cash from Financing	-3.71B	-3.86B	-3.18B	6.59B	5.26B
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	7M	-34M	22M	35M	-37M
Net Change in Cash	59M	-33M	125M	-34M	497M
Supplemental Items
Cash Interest Paid	207M	191M	81M	378M	809M
Cash Income Tax Paid (Refund)	1.18B	1.28B	1.5B	1.12B	1.73B
Levered Free Cash Flow	3.21B	3.18B	2.72B	3.75B	6.36B
Unlevered Free Cash Flow	3.22B	3.2B	2.74B	3.86B	6.76B
Change In Net Working Capital	277M	420M	101M	313M	-2.6B
Net Debt Issued / Repaid	-196M	-152M	848M	10.73B	378M

Fiscal Period: September	2019	2020	2021	2022	2023
Profitability
Return on Assets	28.45	27.86	27	17.03	10
Return on Total Capital	43.84	42.31	39.4	22.79	13.4
Return On Equity %	58.11	58.62	61.96	57.18	37.38
Return on Common Equity	58.11	58.62	61.96	57.18	37.38
Margin Analysis
Gross Profit Margin %	67.99	68.01	68.53	68.78	66.64
SG&A Margin	33.24	32.78	32.16	34.55	35.24
EBITDA Margin %	34.53	34.78	35.4	33.41	30.89
EBITA Margin %	31.74	32.17	33.04	31.48	28.96
EBIT Margin %	31.08	31.53	32.62	30.64	27.96
Income From Continuing Operations Margin %	21.59	22.63	24.84	20.84	19.52
Net Income Margin %	21.59	22.63	24.84	20.84	19.52
Net Avail. For Common Margin %	21.59	22.63	24.84	20.84	19.52
Normalized Net Income Margin	18.89	18.39	20.61	18.23	15.47
Levered Free Cash Flow Margin	17.91	17.16	14.02	16.6	25.97
Unlevered Free Cash Flow Margin	17.93	17.26	14.1	17.08	27.6
Asset Turnover
Asset Turnover	1.46	1.41	1.32	0.89	0.57
Fixed Assets Turnover	6.25	6.18	5.76	5.85	5.52
Receivables Turnover (Average Receivables)	5.95	6.09	6.32	6.31	5.94
Inventory Turnover (Average Inventory)	3.14	2.85	2.63	2.51	2.44
Short Term Liquidity
Current Ratio	1.29	1.3	1.11	1.2	0.61
Quick Ratio	0.86	0.82	0.7	0.72	0.37
Operating Cash Flow to Current Liabilities